Higher circulating adiponectin and lower orosomucoid were associated with postload glucose ≤70 mg/dL, a possible inverse marker for dysglycemia, in young Japanese women.


Journal

BMJ open diabetes research & care
ISSN: 2052-4897
Titre abrégé: BMJ Open Diabetes Res Care
Pays: England
ID NLM: 101641391

Informations de publication

Date de publication:
2019
Historique:
received: 14 08 2018
revised: 16 12 2018
accepted: 28 12 2018
entrez: 23 3 2019
pubmed: 23 3 2019
medline: 23 3 2019
Statut: epublish

Résumé

To examine whether serum adiponectin and orosomucoid were associated with postload glucose ≤70 mg/dL during an oral glucose tolerance test (OGTT), termed as postload low glycemia, a possible inverse marker for dysglycemia. 75 g OGTTs were performed with multiple postload glucose and insulin measurements over a 30-120 min period in 168 normal-weight Japanese women (18-24 years). Insulin resistance (IR) and β-cell function inferred from serum insulin kinetics during OGTT, fat mass and distribution by dual-energy X-ray absorptiometry (DXA), serum adiponectin and inflammatory markers were compared cross-sectionally between 39 women with and 129 women without postload low glycemia. Of 168 women, 161 had normal glucose tolerance. Women with as compared with those without postload low glycemia had lower fasting and postload glycemia despite similar fasting and postload insulinemia. They had higher insulinogenic index (p=0.03) and lower adipose IR (a product of fasting free fatty acid and insulin, p=0.01), although DXA-derived general and central adiposity, the Matsuda Index and homeostasis model assessment-IR did not differ. In addition, they had higher adiponectin and lower orosomucoid (both p<0.001). Multivariate logistic regression analyses revealed that adiponectin (OR: 1.14, 95% CI 1.03 to 1.26, p=0.009) and orosomucoid (0.96, 0.93 to 0.97, p=0.008) were associated with postload low glycemia independently of adipose IR and insulinogenic index. Higher adiponectin and lower orosomucoid were associated with 70 or lower mg/dL of postload glucose, a possible inverse marker for dysglycemia, in young women independently of DXA-derived fat mass and distribution, insulin secretion and IR.

Identifiants

pubmed: 30899529
doi: 10.1136/bmjdrc-2018-000596
pii: bmjdrc-2018-000596
pmc: PMC6398809
doi:

Substances chimiques

Adiponectin 0
Biomarkers 0
Blood Glucose 0
Insulin 0
Orosomucoid 0

Types de publication

Journal Article

Langues

eng

Pagination

e000596

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Clin Med Res. 2017 Aug;9(8):680-686
pubmed: 28725316
Lancet. 1999 May 15;353(9165):1649-52
pubmed: 10335783
Diabetes Res Clin Pract. 2007 Dec;78(3):305-12
pubmed: 17601626
Acta Diabetol. 2016 Dec;53(6):981-989
pubmed: 27581604
Diabetes Care. 2014 Nov;37(11):2940-6
pubmed: 25139885
Diabetes Care. 2000 Aug;23(8):1108-12
pubmed: 10937506
Cell Metab. 2013 May 7;17(5):779-89
pubmed: 23663741
Diabetes. 2003 Jul;52(7):1799-805
pubmed: 12829649
N Engl J Med. 2002 Feb 7;346(6):393-403
pubmed: 11832527
Diabetes Care. 2006 Nov;29(11):2498-503
pubmed: 17065691
Nat Commun. 2018 Jan 18;9(1):272
pubmed: 29348470
Diabetes Care. 2000 Mar;23(3):295-301
pubmed: 10868854
PLoS One. 2012;7(8):e43502
pubmed: 22912885
Sci Rep. 2018 Jan 10;8(1):406
pubmed: 29321603
Diabetes Care. 2004 Feb;27(2):372-7
pubmed: 14747216
J Clin Invest. 2006 Jul;116(7):1784-92
pubmed: 16823476
JAMA. 2009 Jul 8;302(2):179-88
pubmed: 19584347
Diabetes Care. 2012 Aug;35(8):1749-56
pubmed: 22563043
BMJ Open Diabetes Res Care. 2016 Mar 17;4(1):e000194
pubmed: 27026810
Metab Syndr Relat Disord. 2017 Jun;15(5):246-251
pubmed: 28318384
Diabetes Care. 1999 Sep;22(9):1462-70
pubmed: 10480510
J Atheroscler Thromb. 2011;18(5):365-72
pubmed: 21233589
BMJ Open Diabetes Res Care. 2018 Apr 29;6(1):e000508
pubmed: 29732164
Diabetes Care. 2009 Nov;32 Suppl 2:S194-8
pubmed: 19875551
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Diabetes Care. 2006 Jul;29(7):1613-8
pubmed: 16801587
J Clin Endocrinol Metab. 2017 Sep 1;102(9):3600-3609
pubmed: 28911155

Auteurs

Ayaka Tsuboi (A)

Research Institute for Nutrition Sciences, Mukogawa Women's University, Nishinomiya, Hyogo, Japan.
Department of Nutrition, Osaka City Juso Hospital, Osaka, Japan.

Satomi Minato (S)

Research Institute for Nutrition Sciences, Mukogawa Women's University, Nishinomiya, Hyogo, Japan.
Graduate School of Human Science and Environment, University of Hyogo, Himeji, Hyogo, Japan.

Megumu Yano (M)

Research Institute for Nutrition Sciences, Mukogawa Women's University, Nishinomiya, Hyogo, Japan.

Mika Takeuchi (M)

Department of Food Sciences and Nutrition, School of Human Environmental Sciences, Mukogawa Women's University, Nishinomiya, Hyogo, Japan.

Kaori Kitaoka (K)

Research Institute for Nutrition Sciences, Mukogawa Women's University, Nishinomiya, Hyogo, Japan.
Department of Nutritional Sciences for Well-Being, Faculty of Health Sciences for Welfare, Kansai University of Welfare Sciences, Kashiwara, Osaka, Japan.

Miki Kurata (M)

Research Institute for Nutrition Sciences, Mukogawa Women's University, Nishinomiya, Hyogo, Japan.
Department of Food Sciences and Nutrition, School of Human Environmental Sciences, Mukogawa Women's University, Nishinomiya, Hyogo, Japan.

Gen Yoshino (G)

Diabetes Center, Shinsuma Hospital, Kobe, Hyogo, Japan.

Bin Wu (B)

Open Research Center for Studying of Lifestyle-Related Diseases, Mukogawa Women's University Diabetes Division, Nishinomiya, Japan.
Department of Endocrinology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.

Tsutomu Kazumi (T)

Research Institute for Nutrition Sciences, Mukogawa Women's University, Nishinomiya, Hyogo, Japan.
Department of Medicine, Kohnan Kakogawa Hospital, Kakogawa, Hyogo, Japan.

Keisuke Fukuo (K)

Research Institute for Nutrition Sciences, Mukogawa Women's University, Nishinomiya, Hyogo, Japan.
Department of Food Sciences and Nutrition, School of Human Environmental Sciences, Mukogawa Women's University, Nishinomiya, Hyogo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH